Parabilis Medicines, Inc. Investing Cash Flow
Parabilis Medicines, Inc. (PBLS) reported Investing Cash Flow of -$34.43 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13
- 2026-06-30: Net Cash Provided by (Used in) Investing Activities 6 month -$34.43M.
- 2025-06-30: Net Cash Provided by (Used in) Investing Activities 6 month $31.20M.
| Period end | Net Cash Provided by (Used in) Investing Activities 6 month |
|---|---|
| 2026-06-30 | -$34.43M 10-Q · filed 2026-08-13 |
| 2025-06-30 | $31.20M 10-Q · filed 2026-08-13 |